SEC Form 4 · accession 0001731122-18-000180
Enochian Biosciences Inc · ENOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Dybul
Director
Period of report
Nov 21, 2018
Accepted (ET)
Dec 7, 2018 · 1:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001527728
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $6.50 | Nov 21, 2018 | A | 300,000 | A | Nov 21, 2018 | Nov 21, 2018 | Common Stock | 300,000 | 312,834 | D |